0000950170-23-065108.txt : 20231120
0000950170-23-065108.hdr.sgml : 20231120
20231120162116
ACCESSION NUMBER: 0000950170-23-065108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231117
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andersen Jill
CENTRAL INDEX KEY: 0001891047
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 231423046
MAIL ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invivyd, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 819-0080
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Adagio Therapeutics, Inc.
DATE OF NAME CHANGE: 20201112
4
1
ownership.xml
4
X0508
4
2023-11-17
0001832038
Invivyd, Inc.
IVVD
0001891047
Andersen Jill
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
WALTHAM
MA
02451
false
true
false
false
Chief Legal Officer, Secretary
false
Stock Option (Right to Buy)
1.44
2023-11-17
4
A
false
325000
0.00
A
2033-11-16
Common Stock
325000
325000
D
This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of November 17, 2023 and the
remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total
shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen
2023-11-20